Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

SomaLogic, Inc. (SLGC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.09+0.11 (+2.21%)
At close: 04:00PM EDT
5.09 0.00 (0.00%)
After hours: 04:01PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • V
    Vendent
    Great acquisition.
  • B
    BGK
    How do these warrants work?
  • M
    Mars
    the leading proteomics platform on the market with a significant first mover advantage. They can measure over 7,000 proteins in a single sample, far more than any other competitor. The future looks bright, but the ramp up remains to be seen. Revenue for the first half of 2021 was $38.6 million. https://investors.somalogic.com/news-releases/news-release-details/somalogic-reports-first-half-2021-financial-results
  • S
    Scott
    Thoughts on SomaLogic?
  • S
    Susan
    very unique proteomic approach to liquid samples. They have a significant IP moat due to their aptamers. Ability to multiplex targets in a single sample if unsurpassed, expect perhaps by some mass spec applications, but aptamer platform is lower cost and perhaps easier to implement.
  • J
    John
    They gonna drop it $2 b4 buying for next ER. S Bags
  • W
    What
    Will be acquired by Illumina…
  • T
    Terrence
    This stock is amazing on how much it fluctuates. When earnings come out, no way this stays below $10.
  • J
    Jack
    That would be 100 % up very soon because of their discoveries about knowing heart attack before hand..I think nobody aware yet situation.
  • M
    Michelle
    In the first three days of march 2022......13 different officers and directors for SLGC filed ownership disclosures for exercised options.......... NOBODY sold their shares

    https://www.sec.gov/edgar/browse/?CIK=1837412&owner=exclude
  • M
    Mars
    5,520,000 public warrants to purchase common stock (originally sold as part of the units issued in IPO) outstanding along with 5,013,333 private placement warrants issued to Sponsor in a private placement concurrently with IPO. Each warrant entitles its holder to purchase one share of our Class A common stock at an exercise price of $11.50 per whole share. The warrants will become exercisable 30 days after the completion of the Business Combination, and they expire five years after the completion of the Business Combination. The Company may redeem the outstanding public warrants at a price of $0.01 per warrant, if Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30 trading day period. https://www.sec.gov/Archives/edgar/data/1837412/000121390021026384/fs42021_cmlifesci2.htm
  • S
    Steve
    Jefferies initiates at buy with $16 target price.
  • S
    Steve
    11/23 Cowen starts SLGC with $18 price target.
  • J
    Jim
    SLGC's revenue is already doubled and they are projecting big gains in 2022. All SLGC needs is 1 big bit of news and you will see SLGC skyrocket over 70.00. The company is amazing and growing and the services are needed
  • J
    John
    These employees get results, wish the stock did
  • K
    Klaus
    does anyone know anything about the conference/analyst meeting ?
  • M
    Mars
    Sept.1 Form 8 amendment to Form S-4 (File No. 333-256127), originally filed with the SEC on May 14, 2021 https://fintel.io/doc/sec-somalogic-inc-1837412-8a12ba-2021-september-01-18871-2972
  • J
    Jim
    “We are excited about the strong revenue growth we have recognized over the past few years and our outlook for 2022,” said Roy Smythe, M.D., Chief Executive Officer of SomaLogic. “We are growing the size of our commercial team substantially and diversifying our unique offerings for our customers and collaborators. These successful efforts, along with the rapidly increasing demand for proteomics solutions and services means the future is incredibly bright for SomaLogic.”
  • Y
    Yahoo Finance Insights
    SomaLogic is up 7.16% to 13.47
  • Y
    Yahoo Finance Insights
    SomaLogic is up 11.32% to 11.51
Advertisement
Advertisement